Healthcare Services

Blood Plasma Derivatives Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Blood Plasma Derivatives Market During The Forecast Period 2026–2030?

The blood plasma derivatives market has experienced substantial growth in recent years. It is projected to expand from $55.76 billion in 2025 to $60.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. This historical growth can be attributed to the increasing diagnosis of rare blood disorders, the expansion of plasma collection programs, rising demand for albumin therapies, improvements in plasma fractionation techniques, and growing hospital-based plasma usage.

The blood plasma derivatives market size is anticipated to undergo significant expansion over the next few years, projected to reach $86.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period is primarily driven by factors such as the rising incidence of immunodeficiency diseases, escalating investments in plasma-derived therapeutics, the expansion of global plasma donation networks, a heightened focus on achieving self-sufficiency in plasma supply, and advancements in recombinant protein technologies. Prominent trends for this period include an increasing demand for immunoglobulin therapies, a growing adoption of recombinant plasma products, the development of advanced fractionation and purification technologies, an intensified emphasis on pathogen reduction processes, and improved cold chain and plasma processing efficiency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What Underlying Factors Are Accelerating The Growth Of The Blood Plasma Derivatives Market?

The escalating occurrence of hemophilia is projected to fuel the expansion of the blood plasma derivatives market. Hemophilia is defined as an inherited bleeding condition where blood fails to clot correctly, leading to uncontrolled bleeding without an apparent cause, as well as post-injury or post-surgical hemorrhages. For individuals suffering from inherited or acquired disorders affecting hemostasis, blood plasma-derived products or pharmaceuticals offer an effective way to enhance blood clotting. Specifically, factor VIII, factor VIII/vWF, and factor IX concentrates are employed for treating hemophilia A, von Willebrand disease, and hemophilia B, respectively. For instance, data from the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) in 2024, released in October 2025, indicated a 6% rise in the global identification of individuals with hemophilia, a 6% rise in those identified with VWD, and a 9% rise in the detection of other inherited bleeding disorders. Consequently, the growing incidence of hemophilia is propelling the growth of the blood plasma derivatives market.

What Market Segments Are Evaluated Within The Blood Plasma Derivatives Market?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

What Key Trends Are Influencing The Development Of The Blood Plasma Derivatives Market?

Major companies in the blood plasma derivatives market are concentrating on supply chain innovations like intravenous immunoglobulin, which supports the immune system by delivering functional antibodies to patients with immunodeficiency. Intravenous immunoglobulin (IVIg) is a medication created from purified antibodies gathered from the plasma of thousands of healthy donors, used to modulate the immune system. For example, in August 2025, Octapharma, a Switzerland-based human protein products company specializing in plasma-derived and recombinant therapies, introduced Gamten 10% IVIg. This intravenous immunoglobulin (IVIg) product, sourced from UK-donated human plasma under the UK Plasma for Medicines Programme, is designed to provide immunoglobulin replacement therapy for individuals with primary or secondary immunodeficiency. Additionally, the company also provides specialty therapies, encompassing coagulation factors and critical care conditions.

Who Are The Top Market Participants Influencing The Blood Plasma Derivatives Market?

Major companies operating in the blood plasma derivatives market are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Read the full blood plasma derivatives market report here:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Which Region Is Projected To Dominate The Blood Plasma Derivatives Market During The Forecast Period?

North America was the largest region in the blood plasma derivatives market in 2025. The regions covered in the blood plasma derivatives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Blood Plasma Derivatives Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Browse Through More Reports Similar to the Global Blood Plasma Derivatives Market 2026, By The Business Research Company

Therapeutic Plasma Exchange Global Market Report

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Plasma Protein Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Plasma Powder Global Market Report

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795